Study Title
* |
|
Status * |
|
Sponsor * |
|
Protocol Number * |
|
Sponsor Reference * |
|
Drug Name |
|
Drug Brand Name |
|
Primary Sponsor Operating
Location * |
|
Sponsor Contact
Information * |
|
Current Contact
Info: 2 Tesseneer Dr. , Highland Heights, KY
41076
| |
Therapeutic Area |
|
Phase |
|
PPD Global Central Labs
Location * |
|
Business Development
Representative * |
|
Bids and Contracts # |
|
Expected Number of
Sites |
10
|
Expected Number of Patients
Screened |
115 |
Expected Number of
Patients Enrolled/Randomized |
65 |
Expected Number of Patients
Completed |
30 |
Study Population |
Edit...
|
Current
Populations: Geriatric, Min:65,
Max:90 Female Only, Min:n/a,
Max:n/a
| |
Estimated Number of Patients Per
Country |
Edit...
|